• Je něco špatně v tomto záznamu ?

Methamphetamine and sleep impairments: neurobehavioral correlates and molecular mechanisms

M. Vrajová, R. Šlamberová, C. Hoschl, SV. Ovsepian

. 2021 ; 44 (6) : . [pub] 20210611

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc21025589
E-zdroje Online Plný text

NLK Free Medical Journals od 1978 do Před 6 měsíci
ProQuest Central od 2016-10-01 do Před 1 rokem
Health & Medicine (ProQuest) od 2016-10-01 do Před 1 rokem
Psychology Database (ProQuest) od 2016-10-01 do Před 1 rokem

Odkazy

PubMed 33406259
DOI 10.1093/sleep/zsab001
Knihovny.cz E-zdroje

Methamphetamine is a potent and highly addictive psychostimulant, and one of the most widely used illicit drugs. Over recent years, its global usage and seizure have been on a rapid rise, with growing detrimental effects on mental and physical health, and devastating psychosocial impact pressing for intervention. Among the unwanted effects of methamphetamine, acute and long-term sleep impairments are of major concern, posing a significant therapeutic challenge, and a cause of addiction relapse. Unraveling mechanisms and functional correlates of methamphetamine-related sleep and circadian disruption are, therefore, of key relevance to translational and clinical psychiatry. In this article, we review the mounting evidence for the acute and long-term impairements of sleep-wake behavior and circadian activity caused by single or recurring methamphetamine usage and withdrawal. Factors contributing to the severity of sleep loss and related cognitive deficit, with risks of relapse are discussed. Key molecular players mediating methamphetamine-induced dopamine release and neuromodulation are considered, with wake-promoting effects in mesolimbic circuits. The effects on various sleep phases and related changes in dopamine levels in selected subcortical structures are reviewed and compared to other psychostimulants with similar action mechanisms. A critical appraisal is presented of the therapeutic use of modafinil, countering sleep, and circadian rhythm impairments. Finally, emerging knowledge gaps and methodical limitations are highlighted along with the areas for future research and therapeutic translation.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21025589
003      
CZ-PrNML
005      
20211026133656.0
007      
ta
008      
211013s2021 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1093/sleep/zsab001 $2 doi
035    __
$a (PubMed)33406259
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Vrajová, Monika $u Department of Experimental Neurobiology, National Institute of Mental Health, Klecany, Czech Republic
245    10
$a Methamphetamine and sleep impairments: neurobehavioral correlates and molecular mechanisms / $c M. Vrajová, R. Šlamberová, C. Hoschl, SV. Ovsepian
520    9_
$a Methamphetamine is a potent and highly addictive psychostimulant, and one of the most widely used illicit drugs. Over recent years, its global usage and seizure have been on a rapid rise, with growing detrimental effects on mental and physical health, and devastating psychosocial impact pressing for intervention. Among the unwanted effects of methamphetamine, acute and long-term sleep impairments are of major concern, posing a significant therapeutic challenge, and a cause of addiction relapse. Unraveling mechanisms and functional correlates of methamphetamine-related sleep and circadian disruption are, therefore, of key relevance to translational and clinical psychiatry. In this article, we review the mounting evidence for the acute and long-term impairements of sleep-wake behavior and circadian activity caused by single or recurring methamphetamine usage and withdrawal. Factors contributing to the severity of sleep loss and related cognitive deficit, with risks of relapse are discussed. Key molecular players mediating methamphetamine-induced dopamine release and neuromodulation are considered, with wake-promoting effects in mesolimbic circuits. The effects on various sleep phases and related changes in dopamine levels in selected subcortical structures are reviewed and compared to other psychostimulants with similar action mechanisms. A critical appraisal is presented of the therapeutic use of modafinil, countering sleep, and circadian rhythm impairments. Finally, emerging knowledge gaps and methodical limitations are highlighted along with the areas for future research and therapeutic translation.
650    12
$a stimulanty centrálního nervového systému $x škodlivé účinky $7 D000697
650    _2
$a dopamin $7 D004298
650    12
$a methamfetamin $x škodlivé účinky $7 D008694
650    _2
$a modafinil $7 D000077408
650    _2
$a spánek $7 D012890
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a přehledy $7 D016454
700    1_
$a Šlamberová, Romana $u Department of Physiology, Third Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Hoschl, Cyril $u Department of Experimental Neurobiology, National Institute of Mental Health, Klecany, Czech Republic $u Department of Psychiatry and Medical Psychology, Third Faculty of Medicine, Charles University, Klecany, Czech Republic
700    1_
$a Ovsepian, Saak V $u Department of Experimental Neurobiology, National Institute of Mental Health, Klecany, Czech Republic $u Department of Psychiatry and Medical Psychology, Third Faculty of Medicine, Charles University, Klecany, Czech Republic
773    0_
$w MED00004377 $t Sleep $x 1550-9109 $g Roč. 44, č. 6 (2021)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33406259 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20211013 $b ABA008
991    __
$a 20211026133702 $b ABA008
999    __
$a ok $b bmc $g 1714576 $s 1146096
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 44 $c 6 $e 20210611 $i 1550-9109 $m Sleep $n Sleep $x MED00004377
LZP    __
$a Pubmed-20211013

Najít záznam

Citační ukazatele

Možnosti archivace